Counterfeit products pose a pervasive and complex challenge for businesses and consumers around the world. The threat is very real in any industry, but it's particularly dangerous in the pharmaceutical industry. Consumers who unknowingly take fake drugs aren't just paying for something that's not authentic - they're putting their health, and even their lives, at risk. Unfortunately, the problem is widespread, with counterfeits making up more than 10% of the global medicines market, according to the United States FDA's estimates. In some areas - such as developing countries in Africa, as well as parts of Asia and Latin America - almost a third of medicines on sale can be counterfeit. Despite the scope of this challenge, there is hope. Packaging innovations and a layered approach to security and authentication can protect both consumers and pharmaceutical companies.
展开▼
